Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition

Scott Canna; Charlotte Girard; Louise Malle; Adriana de Jesus; Neil Romberg; Judith R. Kelsen; Lea F. Surrey; Pierre Russo; Andrew J. Sleight; Eduardo J. Schiffrin; Cem Gabay; Raphaela Goldbach‐Mansky; Edward M. Behrens

doi:10.1016/j.jaci.2016.10.022

Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition

Scott Canna(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Charlotte Girard(University Hospital of Geneva), Louise Malle(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Adriana de Jesus(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Neil Romberg(Children's Hospital of Philadelphia), Judith R. Kelsen(Children's Hospital of Philadelphia), Lea F. Surrey(Children's Hospital of Philadelphia), Pierre Russo(Children's Hospital of Philadelphia), Andrew J. Sleight(AB2 Bio (Switzerland)), Eduardo J. Schiffrin(AB2 Bio (Switzerland)), Cem Gabay(University Hospital of Geneva), Raphaela Goldbach‐Mansky(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Edward M. Behrens(Children's Hospital of Philadelphia)

Journal of Allergy and Clinical Immunology

November 19, 2016

10.1016/j.jaci.2016.10.022

Cited by 355Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis